Clinical Trial Update: Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigating the immunomodulatory effects of intrathecal morphine, dexmedetomidine, or their combination with bupivacaine in phases 1 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune System Suppression

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Dexmedetomidine (Dexmedetomidine)
• Morphine (morphine)

Snippet

Sponsor: Assiut University | Conditions: Immune System Suppression | Phase 1, Phase 2 | Status: UNKNOWN